Depo Ralovera
Depo Ralovera - Basic Information
- GN: Methylprednisolone acetate
- Con: information not available
- Cla: information not available
Depo Ralovera - Indication of :
Depo-Ralovera can be used in the palliative treatment of recurrent and/or metastatic breast, renal cell or endometrial cancer.It can also be used in the treatment of visually proven endometriosis when pregnancy is the desired treatment outcome, or when surgery is contraindicated or has been unsuccessful.Due to its ovulation-suppressing effects, a high dose of Medroxyprogesterone is also useful as a contraceptive agent. Depo-Ralovera can be administered every three months for this purpose.
Depo Ralovera - Details